Print
Email

Email

TC BioPharm Shares to Move to OTC Markets From Nasdaq

Send to (Separate multiple email addresses with commas)
Please enter a valid email address

Your email address
Please enter a valid email address

Message (Optional)

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Email

Your email has been sent.
Share
Share
TC BioPharm Shares to Move to OTC Markets From Nasdaq

Clicking a link will open a new window.
Default text size A
Larger text size A
Largest text size A

TC BioPharm Shares to Move to OTC Markets From Nasdaq

, MT Newswires - 11:18 AM ET 3/21/2025 US Markets

11:18 AM EDT, 03/21/2025 (MT Newswires) -- TC BioPharm ( TCBP ) said Friday that the Nasdaq Hearings Panel determined to delist the company's shares from the exchange for failing to comply with the minimum bid price requirement.

The company said its shares will be suspended from trading on the Nasdaq at market open March 24.

TC BioPharm ( TCBP ) said it expects its American depositary shares to be eligible to trade on the OTC Markets Monday.

Shares of the company were down over 60% in recent trading.

Price: 0.55, Change: -0.99, Percent Change: -64.09

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

TC BioPharm Shares to Move to OTC Markets From Nasdaq

Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.

Your e-mail has been sent.

US Equity Indexes Rise in Volatile Week Amid Fed's Easing Bias, Economic Uncertainty

MT Newswires - 4:52 PM ET 3/21/2025
Equities Rise as Fed Officials Flag Macro Uncertainty

MT Newswires - 4:51 PM ET 3/21/2025
Brookfield Infrastructure Edging Up In US After Hours As Sells Rest Of Its Interest In US Gas Pipeline

MT Newswires - 4:45 PM ET 3/21/2025
EMERGING MARKETS-Latam currencies pressured by firm dollar after week of rate decisions

Reuters - 4:40 PM ET 3/21/2025
US STOCKS-Dow, S&P end flat, Nasdaq snaps four-week decline on tariff hopes

Reuters - 4:39 PM ET 3/21/2025
Equity Markets Close Higher After Fed Official Remarks

MT Newswires - 4:20 PM ET 3/21/2025
TSX Closer: Down For a Second Session As Investors Brace For More US Tariffs

MT Newswires - 4:18 PM ET 3/21/2025

Content for this page, unless otherwise indicated with a Fidelity pyramid logo, is selected and published by Fidelity Interactive Content Services LLC ("FICS"), a Fidelity company. All Web pages published by FICS will contain this legend. FICS was established to present users with objective news, information, data and guidance on personal finance topics drawn from a diverse collection of sources including affiliated and non-affiliated financial services publications. Content selected and published by FICS drawn from affiliated Fidelity companies is labeled as such. FICS-selected content provided is not intended to provide tax, legal, insurance, or investment advice, and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by any Fidelity entity or any third party. Quotes are delayed unless otherwise noted. FICS is owned by FMR LLC and is an affiliate of Fidelity Brokerage Services LLC. Terms of use for Third-Party Content and Research

These links are provided by Fidelity Brokerage Services LLC ("FBS") for educational and informational purposes only. FBS is responsible for the information contained in the links. FICS and FBS are separate but affiliated companies and FICS is not involved in the preparation or selection of these links, nor does it explicitly or implicitly endorse or approve information contained in the links.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.